JNJ
Johnson & Johnson
NYQ
$222.89
-0.62
(-0.28%)
Pullback · -1.26σ
Grade C
Valuation
Market cap
$536.5B
P/E (ttm)
25.8
Forward P/E
17.5
Beta (5y)
0.26
Shares out
2,407.2M
Div yield
240.00%
Profitability & returns
ROE
26.4%
Net margin
21.8%
FCF margin
13.0%
Debt / equity
0.68
Trading information
Last price
$222.89
Day range
$222.89 – $222.89
52-wk range
$199.91 – $251.71
Avg volume
7.7M
RSI (2)
4.2
TAO zone
Pullback
Company
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYQ
Next earnings
2026-07-15
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular…